Maxigen Biotech Inc. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was TWD 457.691 million compared to TWD 452.199 million a year ago. Operating income was TWD 61.105 million compared to TWD 65.621 million a year ago. Net income was TWD 63.311 million compared to TWD 60.111 million a year ago. Basic earnings per share was TWD 0.91 compared to TWD 0.87 a year ago. Diluted earnings per share was TWD 0.91 compared to TWD 0.82 a year ago.